Invitae Corporation
NYSE:NVTA
0.02 (USD) • At close February 14, 2024
 Overzicht | Financiële gegevens
 | Bedrijfsnaam | Invitae Corporation | 
| Symbool | NVTA | 
| Munteenheid | USD | 
| Prijs | 0.019 | 
| Beurswaarde    |  5,443,367 | 
| Dividendpercentage    |  0% | 
| 52-weken bereik | 0.015 - 2.34 | 
| Industrie | Diagnostics & Research | 
| Sector | Healthcare | 
| CEO | Mr. Kenneth D. Knight | 
| Website | https://www.invitae.com | 
An error occurred while fetching data.
Over Invitae Corporation
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health 
 Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)






